17082-Breast Cancer-NA-421

Breast Cancer

(I3Y-MC-JPCF)A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

  • Details

ClinicalTrials.gov ID: NCT03155997
Diagnosis Type: NA
USOR Number: 17082

  • Address

433 SW 10th Street
Ocala, FL 34471
P: (352) 732-4032

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.